BEST OF THE WEB: A Sars-Cov2 vaccine – don’t hold your breath

[But concern may be in order] I suppose most people believe the trials on vaccines for COVID19 will be looking to demonstrate that they reduce the risk of infection, death, or serious illness – or suchlike. Also, you may have heard that several vaccines could be ready for use early next year 2021. Maybe even later this year. As Dilbert may retort: Hahahahahahahahahahahaha! Oh, let me pause and wipe away my tears of mirth. Really. Think about it. Then think a bit more… AstraZeneca (AZ) is thought to be leading the pack with their vaccine AZD1222. Their major clinical trial will recruit 30,000 participants – which is good. You can find the trial description on It goes by the snappy title ‘Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults.’ 1